Literature DB >> 32619853

Advances of epigenetic editing.

Rutger A F Gjaltema1, Marianne G Rots2.   

Abstract

Epigenetic editing refers to the locus-specific targeting of epigenetic enzymes to rewrite the local epigenetic landscape of an endogenous genomic site, often with the aim of transcriptional reprogramming. Implementing clustered regularly interspaced short palindromic repeat-dCas9 greatly accelerated the advancement of epigenetic editing, yielding preclinical therapeutic successes using a variety of epigenetic enzymes. Here, we review the current applications of these epigenetic editing tools in mammals and shed light on biochemical improvements that facilitate versatile applications.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  CRISPR/dCas; Epigenome editing; Expression reprogramming; Targeted DNA methylation; Targeted histone modifications

Mesh:

Year:  2020        PMID: 32619853     DOI: 10.1016/j.cbpa.2020.04.020

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  12 in total

Review 1.  Tumorigenicity risk of iPSCs in vivo: nip it in the bud.

Authors:  Chaoliang Zhong; Miao Liu; Xinghua Pan; Haiying Zhu
Journal:  Precis Clin Med       Date:  2022-02-03

Review 2.  Monitoring and modulation of the tumor microenvironment for enhanced cancer modeling.

Authors:  Tristen Head; Nathaniel C Cady
Journal:  Exp Biol Med (Maywood)       Date:  2022-01-28

Review 3.  Large-Scale Chromatin Rearrangements in Cancer.

Authors:  Kosuke Yamaguchi; Xiaoying Chen; Asami Oji; Ichiro Hiratani; Pierre-Antoine Defossez
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

Review 4.  DGK and DZHK position paper on genome editing: basic science applications and future perspective.

Authors:  Ralf P Brandes; Anne Dueck; Stefan Engelhardt; Manuel Kaulich; Christian Kupatt; Maria Teresa De Angelis; Matthias S Leisegang; Ferdinand le Noble; Alessandra Moretti; Oliver J Müller; Boris V Skryabin; Thomas Thum; Wolfgang Wurst
Journal:  Basic Res Cardiol       Date:  2021-01-15       Impact factor: 17.165

Review 5.  Expanding the plant genome editing toolbox with recently developed CRISPR-Cas systems.

Authors:  Naoki Wada; Keishi Osakabe; Yuriko Osakabe
Journal:  Plant Physiol       Date:  2022-03-28       Impact factor: 8.340

6.  Analysis of the DNA methylation pattern of the promoter region of calcitonin gene-related peptide 1 gene in patients with episodic migraine: An exploratory case-control study.

Authors:  Elisa Rubino; Silvia Boschi; Elisa Giorgio; Elisa Pozzi; Andrea Marcinnò; Erica Gallo; Fausto Roveta; Alberto Grassini; Alfredo Brusco; Innocenzo Rainero
Journal:  Neurobiol Pain       Date:  2022-04-02

Review 7.  Epigenetic Editing in Prostate Cancer: Challenges and Opportunities.

Authors:  Mariana Brütt Pacheco; Vânia Camilo; Rui Henrique; Carmen Jerónimo
Journal:  Epigenetics       Date:  2021-06-15       Impact factor: 4.861

8.  Lowering DNA binding affinity of SssI DNA methyltransferase does not enhance the specificity of targeted DNA methylation in E. coli.

Authors:  Krystyna Ślaska-Kiss; Nikolett Zsibrita; Mihály Koncz; Pál Albert; Ákos Csábrádi; Sarolta Szentes; Antal Kiss
Journal:  Sci Rep       Date:  2021-07-27       Impact factor: 4.379

Review 9.  Genome Editing among Bioethics and Regulatory Practices.

Authors:  Mauro Mandrioli
Journal:  Biomolecules       Date:  2021-12-22

10.  Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing.

Authors:  Nikolajs Zeps; Tamra Lysaght; Ruth Chadwick; Alexandre Erler; Roger Foo; Simona Giordano; Poh San Lai; G Owen Schaefer; Vicki Xafis; Wei Leong Chew; Jeremy Sugarman
Journal:  Stem Cell Reports       Date:  2021-07-01       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.